Genomic determinants of cancer immunotherapy - PubMed (original) (raw)
Review
Genomic determinants of cancer immunotherapy
Diana Miao et al. Curr Opin Immunol. 2016 Aug.
Abstract
Cancer immunotherapies - including therapeutic vaccines, adoptive cell transfer, oncolytic viruses, and immune checkpoint blockade - yield durable responses in many cancer types, but understanding of predictors of response is incomplete. Genomic characterization of human cancers has already contributed to the success of targeted therapies; in cancer immunotherapy, identification of tumor-specific antigens through whole-exome sequencing may be key to designing individualized, highly immunogenic therapeutic vaccines. Additionally, pre-treatment tumor mutational and gene expression signatures can predict which patients are most likely to benefit from cancer immunotherapy. Continued work in harnessing genomic, transcriptomic, and immunological data from clinical cohorts of immunotherapy-treated patients will bring the promises of precision medicine to immuno-oncology.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
- Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies.
Hartmaier RJ, Charo J, Fabrizio D, Goldberg ME, Albacker LA, Pao W, Chmielecki J. Hartmaier RJ, et al. Genome Med. 2017 Feb 24;9(1):16. doi: 10.1186/s13073-017-0408-2. Genome Med. 2017. PMID: 28231819 Free PMC article. - [Cancer immunotherapy by immuno-checkpoint blockade].
Kawakami Y. Kawakami Y. Rinsho Ketsueki. 2015 Oct;56(10):2186-94. doi: 10.11406/rinketsu.56.2186. Rinsho Ketsueki. 2015. PMID: 26458459 Japanese. - Oncogenic cancer/testis antigens: prime candidates for immunotherapy.
Gjerstorff MF, Andersen MH, Ditzel HJ. Gjerstorff MF, et al. Oncotarget. 2015 Jun 30;6(18):15772-87. doi: 10.18632/oncotarget.4694. Oncotarget. 2015. PMID: 26158218 Free PMC article. Review. - Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy.
Mandal R, Chan TA. Mandal R, et al. Cancer Discov. 2016 Jul;6(7):703-13. doi: 10.1158/2159-8290.CD-16-0146. Epub 2016 Apr 22. Cancer Discov. 2016. PMID: 27107038 Free PMC article. Review. - Biomarkers for Immunotherapy: Current Developments and Challenges.
Spencer KR, Wang J, Silk AW, Ganesan S, Kaufman HL, Mehnert JM. Spencer KR, et al. Am Soc Clin Oncol Educ Book. 2016;35:e493-503. doi: 10.1200/EDBK_160766. Am Soc Clin Oncol Educ Book. 2016. PMID: 27249758
Cited by
- An Integrative Genomics Approach for Associating Genetic Susceptibility with the Tumor Immune Microenvironment in Triple Negative Breast Cancer.
Elnaggar J, Tsien F, Yates C, Davis M, Miele L, Hicks C. Elnaggar J, et al. Biomed J Sci Tech Res. 2019;15(1):11074-11085. doi: 10.26717/bjstr.2019.15.002642. Epub 2019 Feb 25. Biomed J Sci Tech Res. 2019. PMID: 38618278 Free PMC article. - Tumor Vaccines: Unleashing the Power of the Immune System to Fight Cancer.
Liu D, Che X, Wang X, Ma C, Wu G. Liu D, et al. Pharmaceuticals (Basel). 2023 Sep 29;16(10):1384. doi: 10.3390/ph16101384. Pharmaceuticals (Basel). 2023. PMID: 37895855 Free PMC article. Review. - Modulation of Reoviral Cytolysis (II): Cellular Stemness.
Bourhill T, Rohani L, Kumar M, Bose P, Rancourt D, Johnston RN. Bourhill T, et al. Viruses. 2023 Jun 29;15(7):1473. doi: 10.3390/v15071473. Viruses. 2023. PMID: 37515162 Free PMC article. - Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response.
Pagadala M, Sears TJ, Wu VH, Pérez-Guijarro E, Kim H, Castro A, Talwar JV, Gonzalez-Colin C, Cao S, Schmiedel BJ, Goudarzi S, Kirani D, Au J, Zhang T, Landi T, Salem RM, Morris GP, Harismendy O, Patel SP, Alexandrov LB, Mesirov JP, Zanetti M, Day CP, Fan CC, Thompson WK, Merlino G, Gutkind JS, Vijayanand P, Carter H. Pagadala M, et al. Nat Commun. 2023 May 12;14(1):2744. doi: 10.1038/s41467-023-38271-5. Nat Commun. 2023. PMID: 37173324 Free PMC article. - Immunotherapy: an alternative promising therapeutic approach against cancers.
Gupta SL, Basu S, Soni V, Jaiswal RK. Gupta SL, et al. Mol Biol Rep. 2022 Oct;49(10):9903-9913. doi: 10.1007/s11033-022-07525-8. Epub 2022 Jun 27. Mol Biol Rep. 2022. PMID: 35759082 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources